Host-directed Therapy
Host-Directed Therapy is a therapeutic strategy that modulates host immune responses and cellular functions to enhance pathogen clearance, limit tissue damage, and promote disease resolution, distinguishing it from pathogen-targeted approaches by focusing on the host’s biological mechanisms rather than direct antimicrobial activity.
221
Publications
11.5K
Citations
1.9K
Authors
632
Institutions
Publications per year
2017–2026
178
Variants
Hdt
221
1–5 of 221
1.9K
7
h-index
Max Planck Institute for Infection Biology, Germany
6 publications · 437 citations
6
h-index
6
h-index
6
h-index
6
h-index
1–5 of 1.9K
632

Johns Hopkins University
Baltimore, United States
12 h-index
70 publications
3K citations
University College London
London, United Kingdom
12 h-index
19 publications
940 citations

University of Cape Town
Rondebosch, South Africa
12 h-index
63 publications
2.1K citations
National Institute of Allergy and Infectious Diseases
Bethesda, United States
11 h-index
55 publications
13.6K citations

Johns Hopkins Medicine
Baltimore, United States
9 h-index
57 publications
2.4K citations

Howard Hughes Medical Institute
Chevy Chase, United States
9 h-index
24 publications
959 citations
National Institutes of Health
Bethesda, United States
8 h-index
45 publications
12.9K citations
Max Planck Institute for Infection Biology
Berlin, Germany
8 h-index
24 publications
1.9K citations
1–8 of 632
17 publications · 628 citations
15
h-index
14 publications · 539 citations
14
h-index
JID · 13 publications · 655 citations
12
h-index
7 publications · 583 citations
7
h-index
AAC · 7 publications · 151 citations
7
h-index
1–5